The 12th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM 2027)

The 12th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM 2027) focuses on stem cell transplantation, cellular therapies, and advanced hematologic malignancy treatment approaches including CAR T-cell therapy, gene therapy, and transplant-related complications management.

Key Topics

• Bi-specific antibodies CMV infection
• Acute leukemia
• CAR T-cell therapy
• Bone marrow failure syndrome
• Cord blood transplantation
• Cellular therapy
• Genome editing and gene therapy
• Donor lymphocyte infusion
• Haploidentical stem cell transplantation
• GvHD prevention and treatment
• Transplantation
• Hodgkin and Non-Hodgkin lymphoma
• Microbiome
• Mesenchymal stem cell
• Myeloproliferative neoplasm
• Multiple myeloma
• NK Cell therapy
• Myelodysplastic syndrome
• Toxicity post transplantation (VOD, TMA, etc.)
• Relapse prevention
• Virus specific T Cell therapy

Who should Attend

Medical oncologists.